Forte Biosciences
Sherman Oaks
About Forte Biosciences
Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $198.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: nasdaq:FBRX
- Website: fortebiorx.comhomedefault.aspx
- Phone: (858) 625-1025
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Canonical: https://fsome.com/organization/forte-biosciences-42884 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.